Pain Study Using Intermittent Bupivacain Injections After Breast Reconstruction With DIEP Flap

Improved Pain Relief Using Intermittent Bupivacain Injections at the Donor Site After Breast Reconstruction With Deep Inferior Epigastric Artery Perforator (DIEP) Flap

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00804674

Enrollment

Registered

2008-12-09

Start date

2005-08-31

Completion date

2007-05-31

Last updated

2011-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Reconstruction

Keywords

bupivacain, breast, reconstruction, diep, pain, postoperative, catheter, anesthesia

Brief summary

patients are given bupivacain intermittent locally on the donor site after brest reconstruction with diep flap. The hypothesis was that this approach will reduce the need for rescue analgetic medication and pain perception within the three first days

Interventions

DRUGbupivacain

DRUGplacebo

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Yes

Inclusion criteria

* all patients planned to undergo reconstructive breast surgery with a DIEP

Exclusion criteria

* regular use of analgesics * known allergic reaction to bupivacain * bleeding disorders * pregnancy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026